This study will investigate the clinical, functional and neurophysiological effects of automated mechanical peripheral stimulation (AMPS) via the Gondola device administered to patients with chronic stroke, cerebral palsy and Parkinson's Disease. Results will be collected using standardized outcome measures and a transcranial magnetic stimulation assessment protocol including electrical stimulation and electromyographic recording.
The working hypothesis for this pre-post intervention study is that one session of AMPS will increase voluntary motor drive of the plantar-flexors (soleus) muscle. The primary outcome measure will be maximum voluntary contraction (MVC) of the soleus (measured by electromyography, EMG); the secondary outcome will be the MVC of the antagonist muscle, the tibialis anterior. Data will be collected before the first session compared to directly after. The same measures in sham-stimulated and healthy volunteers will serve as controls.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
One treatment session lasts about two minutes and consists of the application of a mechanical pressure pulses on each of the points, one after the other, for a set duration (a few seconds), which is repeated several times in sequence.
Abilities Research Center
New York, New York, United States
Change in Soleus MVC
maximum voluntary contraction of the soleus muscle (measured by EMG)
Time frame: pre and post-AMPS (baseline and 2 minutes)
Change in Tibialis anterior MVC
maximum voluntary contraction of tibialis anterior (measured by EMG)
Time frame: pre and post-AMPS (baseline and 2 minutes)
Change in 10 meter walk test
self-selected pace to determine gait speed
Time frame: pre and post-AMPS (baseline and 2 minutes)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.